Barclays PLC Takeda Pharmaceutical CO LTD Call Options Transaction History

Barclays PLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2021 May 13, 2021	SELL	$16.71 - $19.9 $2.58 Million - $3.07 Million	-154,224 Reduced 50.69%	150,000 $2.74 Million
Q3 2020 Nov 12, 2020	SELL	$17.1 - $19.19 $20,520 - $23,028	-1,200 Reduced 0.39%	304,224 $5.43 Million
Q2 2020 Aug 12, 2020	BUY	$14.59 - $19.5 $586,342 - $783,666	40,188 Added 15.15%	305,424 $5.48 Million
Q1 2020 May 13, 2020	SELL	$13.02 - $20.31 $343,194 - $535,351	-26,359 Reduced 9.04%	265,236 $4.03 Million
Q4 2019 Feb 10, 2020	BUY	$16.88 - $20.83 $364,608 - $449,927	21,600 Added 8.0%	291,595 $5.75 Million
Q3 2019 Nov 14, 2019	SELL	$16.15 - $17.99 $101,809 - $113,408	-6,304 Reduced 2.28%	269,995 $4.64 Million
Q2 2019 Aug 14, 2019	BUY	$16.58 - $20.49 $1.67 Million - $2.06 Million	100,673 Added 57.32%	276,299 $4.89 Million
Q1 2019 May 15, 2019	BUY	$16.7 - $21.52 $2.93 Million - $3.78 Million	175,626 New	175,626 $3.58 Million

337

73.8M

1.96M

165K

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $42.2B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.